Invention Grant
- Patent Title: Inhibiting or alleviating agent for Aβ-induced damage
-
Application No.: US16491638Application Date: 2017-03-06
-
Publication No.: US11235006B2Publication Date: 2022-02-01
- Inventor: Jun Liu
- Applicant: Jun Liu , NIPPON ZOKI PHARMACEUTICAL CO., LTD.
- Applicant Address: CN Guangdong; JP Osaka
- Assignee: Jun Liu,NIPPON ZOKI PHARMACEUTICAL CO., LTD.
- Current Assignee: Jun Liu,NIPPON ZOKI PHARMACEUTICAL CO., LTD.
- Current Assignee Address: CN Guangdong; JP Osaka
- Agency: Oliff PLC
- International Application: PCT/CN2017/075747 WO 20170306
- International Announcement: WO2018/161211 WO 20180913
- Main IPC: A61K35/36
- IPC: A61K35/36 ; A61P25/28 ; A61K9/00
Abstract:
An inhibiting or alleviating agent for amyloid beta (Aβ)-induced damage in hippocampus including an extract from inflamed tissues inoculated with vaccinia virus. Also relates to the use of the extract from inflamed tissues inoculated with vaccinia virus in the preparation of an agent for inhibiting or alleviating Aβ-induced damage in hippocampus.
Public/Granted literature
- US20200289581A1 INHIBITING OR ALLEVIATING AGENT FOR Aß-INDUCED DAMAGE Public/Granted day:2020-09-17
Information query
IPC分类:
